Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption independently of Insulin and Glycemia

Keyphrases

• Glycemia 100%
• Insulin 100%
• Bone Resorption 100%
• Glucose-dependent Insulinotropic Polypeptide 100%
• Procollagen Type 1 N-terminal Propeptide (P1NP) 45%
• Placebo 27%
• Plasma Glucose 18%
• Saline Injection 18%
• Insulin Release 18%
• Type I Diabetes 9%
• Type 1 Diabetes Mellitus (T1DM) 9%
• Glycemic Status 9%
• C-peptide 9%
• Glucagon-like 9%
• Postprandial Insulin 9%
• Absolute Value 9%
• Collagen Cross-linking 9%
• Gut Hormones 9%
• Bone Homeostasis 9%
• Endogenous Insulin Secretion 9%
• Carboxyl Terminus 9%
• Type I Procollagen 9%

Medicine and Dentistry

• Osteolysis 100%
• Gastric Inhibitory Polypeptide 100%
• Parathyroid Hormone 36%
• Placebo 27%
• Sodium Chloride 27%
• Infusion 27%
• Insulin Release 27%
• Amino Terminal Sequence 9%
• Biological Marker 9%
• Glycemic 9%
• C-Peptide 9%
• Patient with Type 1 Diabetes 9%
• Gastrointestinal Hormone 9%
• Homeostasis 9%
• Glucagon Like Peptide 1 9%
• Cross-Link 9%
• Carboxy Terminal Sequence 9%
• Procollagen 9%

Biochemistry, Genetics and Molecular Biology

• Glucose Blood Level 100%
• Osteolysis 100%
• Gastric Inhibitory Polypeptide 100%
• Parathyroid Hormone 36%
• Insulin Release 27%
• C-Peptide 9%
• N-Terminus 9%
• Homeostasis 9%
• C-Terminus 9%
• Glucagon-Like Peptide-1 9%
• Glucose Level 9%
• Cross-Link 9%